BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25237769)

  • 21. TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer.
    Sparano JA; Goldstein LJ; Davidson NE; Sledge GW; Gray R
    Breast Cancer Res Treat; 2012 Jul; 134(2):751-7. PubMed ID: 22706628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
    Dakhova O; Rowley D; Ittmann M
    Clin Cancer Res; 2014 Jan; 20(1):100-9. PubMed ID: 24150235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
    Ngalame NN; Tokar EJ; Person RJ; Waalkes MP
    Toxicol Sci; 2014 Dec; 142(2):489-96. PubMed ID: 25273566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.
    Mitrović O; Čokić V; Đikić D; Budeč M; Vignjević S; Subotički T; Gulan M; Radović S; Furtula S
    Target Oncol; 2014 Dec; 9(4):367-79. PubMed ID: 24272208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
    Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
    Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
    Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
    Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
    Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.
    Belluti S; Basile V; Benatti P; Ferrari E; Marverti G; Imbriano C
    Cell Death Dis; 2013 Aug; 4(8):e756. PubMed ID: 23928695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis.
    Castellón EA; Valenzuela R; Lillo J; Castillo V; Contreras HR; Gallegos I; Mercado A; Huidobro C
    Biol Res; 2012; 45(3):297-305. PubMed ID: 23283439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
    Yang Y; Sun P; Xu W; Xia W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809694. PubMed ID: 30376767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
    Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
    Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.
    Gobble RM; Qin LX; Brill ER; Angeles CV; Ugras S; O'Connor RB; Moraco NH; Decarolis PL; Antonescu C; Singer S
    Cancer Res; 2011 Apr; 71(7):2697-705. PubMed ID: 21335544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
    Fountzilas G; Christodoulou C; Bobos M; Kotoula V; Eleftheraki AG; Xanthakis I; Batistatou A; Pentheroudakis G; Xiros N; Papaspirou I; Koumarianou A; Papakostas P; Bafaloukos D; Skarlos DV; Kalogeras KT
    J Transl Med; 2012 Oct; 10():212. PubMed ID: 23092535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.